David Kideckel

David Kideckel

Chairman at PHARMADRUG INC.

Net worth: - $ as of 30/04/2024

Finance
Consumer Services
Health Technology

Profile

David M.
Kideckel
is currently the Chairman at Pharmadrug, Inc., the Senior VP, Head-Corporate Development & Strategic at IntelGenx Technologies Corp., and the EVP, Head-Strategy & Corporate Development at Delta 9 Cannabis, Inc. Previously, he worked as an Analyst & Managing Director at ATB Capital Markets, Inc. from 2018 to 2021.
He also held the position of Director of Equity Research at Beacon Securities Ltd.
Dr. Kideckel holds an MBA from Rotman School of Management and a doctorate from the University of Toronto.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/04/2023 0 ( -.--% ) - $ 30/04/2024
07/11/2023 0 ( -.--% ) - $ 30/04/2024

David Kideckel active positions

CompaniesPositionStart
DELTA 9 CANNABIS INC. Corporate Officer/Principal 16/08/2021
PHARMADRUG INC. Chairman 27/02/2024
INTELGENX TECHNOLOGIES CORP. Corporate Officer/Principal 20/03/2023
All active positions of David Kideckel

Former positions of David Kideckel

CompaniesPositionEnd
Analyst-Equity 01/08/2021
Director of Research - Equity -
See the detail of David Kideckel's experience

Training of David Kideckel

University of Toronto Doctorate Degree
Rotman School of Management Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Kideckel's experience

Connections

56

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
DELTA 9 CANNABIS INC.

Distribution Services

PHARMADRUG INC.

Health Technology

INTELGENX TECHNOLOGIES CORP.

Health Technology

Private companies2

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. David Kideckel
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW